Permanent hypoparathyroidism following SARS-CoV-2 infection: a case report with two-year follow-up and literature review
-
By
-
Yizhi Zu
-
Hang Wang
-
Jinlin Wu
-
Cai Tang
-
Rui Han
-
Fang Fang
-
May 25, 2026
-
Clinical Scorecard: Long-term Hypoparathyroidism After SARS-CoV-2 Infection: A Case Study with Two-Year Follow-Up and Review of Existing Literature
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Young adults without a history of neck surgery. |
| Care Setting | |
Key Highlights
- Severe symptomatic hypocalcemia developed shortly after SARS-CoV-2 infection.
- Laboratory evaluation showed low PTH levels and hyperphosphatemia.
- Coexisting Hashimoto’s thyroiditis may indicate an autoimmune contribution.
- Extended follow-up is essential for patients with hypocalcemia and blunted PTH responses.
Guideline-Based Recommendations
Diagnosis
- Consider autoimmune evaluation and genetic testing for patients with persistent hypocalcemia.
Management
- Regular calcium and vitamin D supplementation.
Monitoring & Follow-up
- Serial monitoring of calcium and PTH levels over time.
Risks
- Potential for new-onset HypoPT or worsening of pre-existing conditions post-COVID-19.
Patient & Prescribing Data
Young adult female with no prior history of neck surgery.
Calcium and vitamin D supplementation were utilized to manage hypocalcemia.
Clinical Best Practices
- Conduct comprehensive autoimmune evaluations in patients with hypocalcemia post-COVID-19.
- Ensure long-term follow-up for patients with suspected HypoPT.
Related Resources & Content
